US20030113350A1 - Glycoconjugate vaccines for use in immune-compromised populations - Google Patents

Glycoconjugate vaccines for use in immune-compromised populations Download PDF

Info

Publication number
US20030113350A1
US20030113350A1 US09/955,585 US95558501A US2003113350A1 US 20030113350 A1 US20030113350 A1 US 20030113350A1 US 95558501 A US95558501 A US 95558501A US 2003113350 A1 US2003113350 A1 US 2003113350A1
Authority
US
United States
Prior art keywords
antigen
vaccine
comprises
type
method according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/955,585
Inventor
Ali Fattom
Robert Naso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NABI
Original Assignee
NABI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NABI filed Critical NABI
Priority to US09/955,585 priority Critical patent/US20030113350A1/en
Assigned to NABI reassignment NABI ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FATTOM, ALI I., NASO, ROBERT B.
Priority claimed from NZ531647A external-priority patent/NZ531647A/en
Publication of US20030113350A1 publication Critical patent/US20030113350A1/en
Assigned to NABI BIOPHARMACEUTICALS reassignment NABI BIOPHARMACEUTICALS MERGER (SEE DOCUMENT FOR DETAILS). Assignors: NABI
Application status is Abandoned legal-status Critical

Links